Aim To investigate the protein expression and biological significance of NADPH oxidase l (NOX1) on the growth of human gastrointestinal stromal tumor (GIST), and to test the correlation between NOX1 expression level and patient prognosis.Methods We collected surgical specimens from a series of 146 GIST patients and used immunohistochemistry (IHC) coupled with a GIST tissue microarray to assess the expression pattern of NOXl in GIST. NOX1 mRNA expression in GIST was subsequently confirmed using the online database Oncomine.Results There was a significance association with mitotic index (χ2 = 9.476, p = 0.009) and tumor grade (χ2 = 11.392, p =0.010) in GIST cells with low cytoplasmic NOX1 cytoplasm staining, which comprised 78 of 146 (53.42%) of GIST samples. Univariate analysis showed that overall survival (OS) rate of GIST patients correlated positively with their NOX1 expression level (c2=2.429, p=0.014), tumor diameter (c2=2.048, p=0.004), mitotic index (c2=2.665, p<0.001), and grade (c2=3.162, p=0.001). Moreover, multivariate analyses demonstrated that low cytoplasm expression of NOX1 (c2=2.144, p=0.046) and mitotic index (c2=2.513, p=0.001) had striking effects on OS. Kaplan-Meier survival plots confirmed that patients with low cytoplasmic NOX1 expression and higher mitotic index had an unfavorable prognosis.Conclusion The present study unveils that cytoplasmic NOX1 cytoplasm expression and mitotic index is associated with the development of GIST, in support of NOX1-based gene therapy in treating GIST.
Objective: To investigate the expression effect and biological significance of NADPH oxidase l (NOX1) on the growth of human Gastrointestinal stromal tumor (GIST) at a protein level and the correlation between its expression level and patient prognosis.Methods: We enrolled a total of 146 patients confirmed by histopathology to be GIST tumors. Immunohistochemistry(IHC) analysis with GIST tissue microarray was used to assess NOXl level. The relativity study between NOXl expression level and GIST patient prognosis was evaluated. NOX1 mRNA expression was subsequently demonstrated using online database Oncomine.Results: Significance association with mitotic index (χ2 = 9.476, p = 0.009) and grade (χ2 = 11.392, p =0.010) was observed for low NOX1 cytoplasm staining of GIST cells and poor performance status in 78 of 146 (53.42%) GIST tissues, while for GIST patients with high expression of NOX1, there was no significant survival difference in disease progression. By univariate analysis, prognosis of GIST patients for overall survival (OS) rates were significantly positively correlated with NOX1 expression level (c2=2.429, p=0.014), tumor diameter (c2=2.048, p=0.004), mitotic index (c2=2.665, p<0.001), and grade (c2=3.162, p=0.001). Moreover, multivariate analyses demonstrated that low cytoplasm expression of NOX1 (c2=2.144, p=0.046) and mitotic index (c2=2.513, p=0.001) were striking related with OS rates, the difference was statistically significant. Kaplan-Meier survival curves further exhibited that low NOX1 cytoplasm expression and advanced mitotic index had a more unfavorable prognosis in GIST patients.Conclusion: These conclusions indicate that the degree of malignancy of GIST patients is closely related to NOX1 cytoplasm expression and mitotic index, both of which may be taken as an important role in the occurrence and development of GIST. It may act as an unfavorable predictive marker, indicating a new approach of gene therapy for GIST.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.